跳至主要内容
临床试验/NCT04198961
NCT04198961已完成不适用

An Electronic Chart Intervention to Improve Safety for Patients on Chronic Opioid Therapy

Stanford University2 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2020年6月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
43
试验地点
2
主要终点
Change in the number of patients who receives naloxone prescription

研究概览

简要总结

This pilot study will attempt to apply an electronic chart intervention to improve safety for patients on chronic opioid medications.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients prescribed long-term opioid therapy of doses greater than 90 morphine equivalent daily dose (MEDD)

排除标准

  • Patients prescribed short-term opioid medications for acute pain (less than a 90-day supply over the past 120 days), sublingual buprenorphine, methadone maintenance for opioid use disorder or with oncology or palliative care diagnoses will be excluded.

结局指标

主要结局

Change in the number of patients who receives naloxone prescription

时间窗: baseline, 1, 3- and 6-months and 12 months

Change in the number of patients who receives naloxone prescription

change of number of documentation about safety discussions

时间窗: baseline, 1, 3- and 6-months and 12 months

change of number of documentation about safety discussions

change of number of order for urine toxicology screening

时间窗: baseline, 1, 3- and 6-months and 12 months

change of number of order for urine toxicology screening

change of number of documentation of prescription drug monitoring program (CURES) results

时间窗: baseline, 1, 3- and 6-months and 12 months

change of number of documentation of prescription drug monitoring program (CURES) results

change of number of signed opioid informed consent forms

时间窗: baseline, 1, 3- and 6-months and 12 months

change of number of signed opioid informed consent forms

次要结局

  • Change in number of patients on long-term high risk doses of opioid pain medications(baseline, 1, 3- and 6-months and 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Huiqiong Deng

Clinical Assistant Professor

Stanford University

研究点 (2)

Loading locations...

相似试验